Regencell Bioscience Holdings (RGC) Prepaid Assets (2021 - 2025)
Regencell Bioscience Holdings' (RGC) quarterly Prepaid Assets came in at $5798.0 in Q2 2025, down 96.2% YoY from $152778.0 in Q2 2024, and down 96.2% on a QoQ basis from $152778.0 in Q2 2024.
Regencell Bioscience Holdings (RGC) Prepaid Assets (2021 - 2025) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 5 years of Prepaid Assets data on file, last reported at $5798.0 in Q2 2025.
- Quarterly Prepaid Assets fell 96.2% year-over-year to $5798.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $5798.0 (down 96.2% YoY) and the FY2025 annual result came in at $5798.0, down 96.2% from the prior year.
- Prepaid Assets declined to $5798.0 in Q2 2025, from $152778.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $152778.0 in Q2 2024 to a low of $5798.0 in Q2 2025.
- A 5-year average of $50031.6 and a median of $27598.0 in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets jumped 271.14% — and 2025, when it plunged 96.2%.
- Tracing RGC's Prepaid Assets over 5 years: stood at $7436.0 in 2021, then jumped by 271.14% to $27598.0 in 2022, then soared by 104.9% to $56548.0 in 2023, then jumped by 170.17% to $152778.0 in 2024, then sank by 96.2% to $5798.0 in 2025.
- The last three Prepaid Assets figures came in at $5798.0 (Q2 2025), $152778.0 (Q2 2024), and $56548.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Regencell Bioscience Holdings | 2.61 Bn | 2.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 5,798.00 |
| Jun 30, 2024 | 152,778.00 |
| Jun 30, 2023 | 56,548.00 |
| Jun 30, 2022 | 27,598.00 |
| Jun 30, 2021 | 7,436.00 |